Mineralys Therapeutics (MLYS) Q4 2024 Earnings

Nov 11Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.13
-0.96
-0.78
-0.61

Details

Expected EPS
-0.863333
Actual EPS
-1.13
Surprise EPS
-0.27
Surprise Percent
-30.89%

Description

⁨Mineralys Therapeutics⁩ (⁦MLYS⁩) has reported earnings of ⁦-1.13⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts